Mattifying Tonic

Product NDC: 68828-102
11-digit product format: 688280102
Labeler code: 68828
Product ID: 68828-102_a8b440d1-7f1c-3699-e053-2a95a90a7a48
Type: HUMAN OTC DRUG
Nonproprietary name: Salicylic Acid
Dosage form: LIQUID
Route: TOPICAL
Labeler: JAFRA COSMETICS INTERNATIONAL
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2012-06-19
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 1 g/100mL
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68828-102		I	Inactivated by FDA		2026-10-05
excluded package	package	68828-102	68828-102-01	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 38 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68828-102-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68828-102-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68828-102-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68828-102-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68828-102-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68828-102-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68828-102-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68828-102-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68828-102-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68828-102-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68828-102-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68828-102-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68828-102-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68828-102-01	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68828-102-01	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68828-102-01	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68828-102-01	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68828-102-01	`bd6a592717d7…`	`303034d00443…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68828-102-01	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68828-102-01	2022-01-28	C162847	48780-1	9d75b9d0-c3be-f424-e053-dadaa90a57ce	Jafra Mattifying Tonic
68828-102-01	2020-06-22	C162847	48780-1	9d75b9d0-c3be-f424-e053-dadaa90a57ce	Jafra Mattifying Tonic
68828-102-01	2020-01-31	C162847	48780-1	9d75b9d0-c3be-f424-e053-dadaa90a57ce	Jafra Mattifying Tonic

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68828-102-01	Mattifying TonicJafra	200 mL in 1 BOTTLE, PLASTIC	LIQUID	200		5
68828-102-01	Mattifying TonicJafra	1 in 1 CARTON	LIQUID	1		5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
DIAZOLIDINYL UREA	INACTIVE INGREDIENT	H5RIZ3MPW4	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
IODOPROPYNYL BUTYLCARBAMATE	INACTIVE INGREDIENT	603P14DHEB	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
KAOLIN	INACTIVE INGREDIENT	24H4NWX5CO	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
SODIUM PYRROLIDONE CARBOXYLATE	INACTIVE INGREDIENT	469OTG57A2	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
SULISOBENZONE	INACTIVE INGREDIENT	1W6L629B4K	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
ZINC GLUCONATE	INACTIVE INGREDIENT	U6WSN5SQ1Z	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2
ZINC OXIDE	INACTIVE INGREDIENT	SOI2LOH54Z	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68828-102	MATTIFYING TONIC JAFRA (SALICYLIC ACID) LIQUID [JAFRA COSMETICS INTERNATIONAL]	5	Legacy NDC, 2 package rows	20200623_446c43b9-b29f-4c9a-bdf2-1844571c428f.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
199308	salicylic acid 0.5 % Topical Solution	PSN	446c43b9-b29f-4c9a-bdf2-1844571c428f	5
199308	salicylic acid 5 MG/ML Topical Solution	SCD	446c43b9-b29f-4c9a-bdf2-1844571c428f	5
199308	salicylic acid 0.5 % Topical Solution	SY	446c43b9-b29f-4c9a-bdf2-1844571c428f	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
68828-102-01	68828010201	1 BOTTLE, PLASTIC in 1 CARTON (68828-102-01) > 200 mL in 1 BOTTLE, PLASTIC	2012-06-19	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Jafra Mattifying Tonic	JAFRA COSMETICS INTERNATIONAL \| Jafra Manufacturing, S.A. de C.V.	2020-06-22	HUMAN OTC DRUG LABEL	5